CFDE Workbench
Information PortalData PortalKnowledge Portal
Search
Graph
Enrichment
Cross
Assistant
Data Matrix
Use Cases
Tools & Workflows
Submit
Documentation
CFDE Workbench

Hyperuricemia (Disease Or Phenotype)

Omim:MTHU004766
Nci:C3961
Msh:D033461
Medcin:MEDCIN:363338
Mdr:MDR:10020903
Id:1512374d-6d59-544b-a147-8f8f666fd39a
Icpc2icd10eng:MTHU078166
Efo:EFO:9104
Doid:DOID:1920
Chv:CHV:47106
Results found

Linked to

 

Label

Description

 

Knowledge Graph Assertion

febuxostat indication Hyperuricemia

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from IDG

Knowledge Graph Assertion

Allopurinol indication Hyperuricemia

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from IDG

Knowledge Graph Assertion

4-[5-(4-Pyridinyl)-1H-1,2,4-triazol-3-yl]pyridine-2-carbonitrile indication Hyperuricemia

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from IDG

Knowledge Graph Assertion

SID11110651 indication Hyperuricemia

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from IDG

Knowledge Graph Assertion

Dotinurad indication Hyperuricemia

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from IDG

Knowledge Graph Assertion

sufinpyrazone indication Hyperuricemia

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from IDG

Knowledge Graph Assertion

probenecid indication Hyperuricemia

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from IDG

  • Knowledge Graph Assertion

    febuxostat indication Hyperuricemia

    Knowledge Graph Assertion (Entity type)

    A Knowledge Graph Assertion from IDG

  • Knowledge Graph Assertion

    Allopurinol indication Hyperuricemia

    Knowledge Graph Assertion (Entity type)

    A Knowledge Graph Assertion from IDG

  • Knowledge Graph Assertion

    4-[5-(4-Pyridinyl)-1H-1,2,4-triazol-3-yl]pyridine-2-carbonitrile indication Hyperuricemia

    Knowledge Graph Assertion (Entity type)

    A Knowledge Graph Assertion from IDG

  • Knowledge Graph Assertion

    SID11110651 indication Hyperuricemia

    Knowledge Graph Assertion (Entity type)

    A Knowledge Graph Assertion from IDG

  • Knowledge Graph Assertion

    Dotinurad indication Hyperuricemia

    Knowledge Graph Assertion (Entity type)

    A Knowledge Graph Assertion from IDG

  • Knowledge Graph Assertion

    sufinpyrazone indication Hyperuricemia

    Knowledge Graph Assertion (Entity type)

    A Knowledge Graph Assertion from IDG

  • Knowledge Graph Assertion

    probenecid indication Hyperuricemia

    Knowledge Graph Assertion (Entity type)

    A Knowledge Graph Assertion from IDG

    • DISPLAY PER PAGE
    CFDE Workbench
    Report a bug
    Consortium
    About the CFDECF ProgramsCFDE CentersPartnershipsPilot Projects
    Community
    Workbench TutorialTraining & OutreachDocumentationGet QR CodesFunding Opportunities
    Resources
    Data & MetadataToolsChatbotUse CasesPublications
    @CFDE Workbench 2025
    The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.
    Consortium
    About the CFDECF ProgramsCFDE CentersPartnershipsPilot Projects
    Community
    Workbench TutorialTraining & OutreachDocumentationGet QR CodesFunding Opportunities
    Resources
    Data & MetadataToolsChatbotUse CasesPublications
    CFDE Workbench
    Report a bug
    The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.
    @CFDE Workbench 2025
    This repository is under review for potential modification in compliance with Administration directives.